183 related articles for article (PubMed ID: 19605746)
1. Optimalization of the clinical pharmacogenetic model to predict methotrexate treatment response: the influence of the number of haplotypes of MTHFR 1298A-677C alleles on probability to respond.
Kooloos WM; Wessels JA; van der Kooij SM; Allaart CF; Huizinga TW; Guchelaar HJ
Ann Rheum Dis; 2009 Aug; 68(8):1371. PubMed ID: 19605746
[No Abstract] [Full Text] [Related]
2. Race and methotrexate pharmacogenetics in rheumatoid arthritis.
Ranganathan P; McLeod H
J Rheumatol; 2010 May; 37(5):1064; author reply 1065. PubMed ID: 20439524
[No Abstract] [Full Text] [Related]
3. Pharmacogenomics of methotrexate in rheumatoid arthritis: does race make a difference?
Dervieux T
J Rheumatol; 2008 Apr; 35(4):550-2. PubMed ID: 18398948
[No Abstract] [Full Text] [Related]
4. Efficacy and toxicity of methotrexate in early rheumatoid arthritis are associated with single-nucleotide polymorphisms in genes coding for folate pathway enzymes.
Wessels JA; de Vries-Bouwstra JK; Heijmans BT; Slagboom PE; Goekoop-Ruiterman YP; Allaart CF; Kerstens PJ; van Zeben D; Breedveld FC; Dijkmans BA; Huizinga TW; Guchelaar HJ
Arthritis Rheum; 2006 Apr; 54(4):1087-95. PubMed ID: 16572443
[TBL] [Abstract][Full Text] [Related]
5. 677C>T and 1298A>C MTHFR polymorphisms affect methotrexate treatment outcome in rheumatoid arthritis.
Kurzawski M; Pawlik A; Safranow K; Herczynska M; Drozdzik M
Pharmacogenomics; 2007 Nov; 8(11):1551-9. PubMed ID: 18034620
[TBL] [Abstract][Full Text] [Related]
6. The pharmacogenetics of methotrexate.
Hider SL; Bruce IN; Thomson W
Rheumatology (Oxford); 2007 Oct; 46(10):1520-4. PubMed ID: 17586865
[TBL] [Abstract][Full Text] [Related]
7. Validation of the associations between single nucleotide polymorphisms or haplotypes and responses to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a proposal for prospective pharmacogenomic study in clinical practice.
Taniguchi A; Urano W; Tanaka E; Furihata S; Kamitsuji S; Inoue E; Yamanaka M; Yamanaka H; Kamatani N
Pharmacogenet Genomics; 2007 Jun; 17(6):383-90. PubMed ID: 17502830
[TBL] [Abstract][Full Text] [Related]
8. 667C>T and 1298A>C polymorphisms of MTHFR do not predict response to methotrexate in patients with gestational trophoblastic neoplasia.
Lasecka L; Dixon PH; Molokhia M; Sharma N; Schleh A; Wang CM; Steel JH; Seckl MJ; Savage PM; Fisher RA
Gynecol Oncol; 2011 Dec; 123(3):605-9. PubMed ID: 21920590
[TBL] [Abstract][Full Text] [Related]
9. Racial or ethnic differences in allele frequencies of single-nucleotide polymorphisms in the methylenetetrahydrofolate reductase gene and their influence on response to methotrexate in rheumatoid arthritis.
Hughes LB; Beasley TM; Patel H; Tiwari HK; Morgan SL; Baggott JE; Saag KG; McNicholl J; Moreland LW; Alarcón GS; Bridges SL
Ann Rheum Dis; 2006 Sep; 65(9):1213-8. PubMed ID: 16439441
[TBL] [Abstract][Full Text] [Related]
10. [Tailor-made medicine and genomic drug discovery in rheumatoid arthritis].
Taniguchi A; Kamatani N
Nihon Rinsho; 2005 Jan; 63 Suppl 1():686-90. PubMed ID: 15799443
[No Abstract] [Full Text] [Related]
11. The effect of 677C>T and 1298A>C MTHFR polymorphisms on sulfasalazine treatment outcome in rheumatoid arthritis.
Pawlik A; Kurzawski M; Gawronska-Szklarz B; Gornik W; Dziedziejko V; Safranow K; Juzyszyn Z; Drozdzik M
Braz J Med Biol Res; 2009 Jul; 42(7):660-4. PubMed ID: 19578646
[TBL] [Abstract][Full Text] [Related]
12. Association of methotrexate effects and single-nucleotide polymorphisms in the folate pathway in rheumatoid arthritis: comment on the article by Wessels et al.
Ranganathan P
Arthritis Rheum; 2006 Oct; 54(10):3372; author reply 3372-3. PubMed ID: 17009311
[No Abstract] [Full Text] [Related]
13. Methotrexate pharmacogenomics.
Kremer JM
Ann Rheum Dis; 2006 Sep; 65(9):1121-3. PubMed ID: 16905578
[TBL] [Abstract][Full Text] [Related]
14. [Methylenetetrahydrofolate reductase polymorphisms in methotrexate treatment of rheumatoid arthritis patients. Review of the literature and personal experience].
Taraborelli M; Andreoli L; Archetti S; Ferrari M; Cattaneo R; Tincani A
Reumatismo; 2009; 61(2):98-106. PubMed ID: 19633796
[TBL] [Abstract][Full Text] [Related]
15. Genetic determinants of methotrexate treatment in rheumatoid arthritis patients: a study of polymorphisms in the adenosine pathway.
Grabar PB; Rojko S; Logar D; Dolzan V
Ann Rheum Dis; 2010 May; 69(5):931-2. PubMed ID: 20413572
[No Abstract] [Full Text] [Related]
16.
Wang YC; Wu MT; Tang FY; Chen DY; Ko HA; Shane B; Huang WN; Chiang EP
Clin Sci (Lond); 2019 Jan; 133(2):253-267. PubMed ID: 30606816
[No Abstract] [Full Text] [Related]
17. 677C > T and 1298A > C MTHFR polymorphisms affect arechin treatment outcome in rheumatoid arthritis.
Pawlik A; Kurzawski M; Górnik W; Dabrowska-Zamojcin E; Droździk M
Pharmacol Rep; 2007; 59(6):721-6. PubMed ID: 18195462
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacogenomics of the immunosuppressive agents].
Taniguchi A; Urano W; Tanaka E; Kitamura Y; Saito M; Akama H; Yamanak H; Saito T; Kamatani N
Nihon Rinsho Meneki Gakkai Kaishi; 2002 Feb; 25(1):105-9. PubMed ID: 11963167
[No Abstract] [Full Text] [Related]
19. MTHFR functional genetic variation and methotrexate treatment response in rheumatoid arthritis: a meta-analysis.
Morgan MD; Al-Shaarawy N; Martin S; Robinson JI; Twigg S; ; Magdy AA; Omar AS; Ghattas MH; Emery P; Barrett JH; Morgan AW
Pharmacogenomics; 2014 Mar; 15(4):467-75. PubMed ID: 24624914
[TBL] [Abstract][Full Text] [Related]
20. [The importance of pharmacogenetic tests in evaluation of the effectiveness of methotrexate treatment in rheumatoid arthritis (part 2)].
Swierkot J; Slęzak R
Postepy Hig Med Dosw (Online); 2011 Mar; 65():207-15. PubMed ID: 21502697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
